FDA approves TMS for obsessive compulsive disorder treatment
Written By : Dr. Kamal Kant Kohli
Published On 2020-08-12 03:46 GMT | Update On 2020-08-12 03:50 GMT
Image courtesy of PR Newswire.
The US Food and Drug Administration (FDA) has granted approval to transcranial magnetic stimulation (TMS Therapy) for adjunct treatment in adult patients with obsessive-compulsive disorder.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd